Pharmacodynamics of spironolactone
Pharmacodynamics of Spironolactone[edit]
Spironolactone is a potassium-sparing diuretic and an aldosterone antagonist used primarily in the treatment of heart failure, hypertension, and conditions of hyperaldosteronism. It functions by inhibiting the effects of aldosterone in the distal renal tubules, leading to increased excretion of sodium and water while retaining potassium.
Mechanism of Action[edit]
Spironolactone acts as a competitive antagonist of the mineralocorticoid receptor in the distal convoluted tubule and collecting duct of the nephron. By blocking aldosterone, spironolactone reduces the reabsorption of sodium and water, which decreases blood volume and lowers blood pressure. This mechanism also prevents the excretion of potassium, making it a potassium-sparing diuretic.
Clinical Uses[edit]
Spironolactone is used in the management of several conditions:
- Heart failure: It reduces morbidity and mortality by decreasing fluid overload and cardiac workload.
- Hypertension: Used as an adjunct therapy to control blood pressure.
- Hyperaldosteronism: Treats conditions like Conn's syndrome by counteracting excessive aldosterone.
- Edema: Associated with liver cirrhosis and nephrotic syndrome.
- Polycystic ovary syndrome (PCOS): Used off-label for its anti-androgen effects.
Pharmacokinetics[edit]
Spironolactone is well absorbed orally, with a bioavailability of approximately 70%. It is metabolized in the liver to active metabolites, including canrenone, which contribute to its therapeutic effects. The drug and its metabolites are primarily excreted in the urine.
Adverse Effects[edit]
Common side effects of spironolactone include:
- Hyperkalemia: Due to potassium retention, which can lead to serious cardiac complications.
- Gynecomastia: Due to its anti-androgen effects, particularly in males.
- Menstrual irregularities: In females, due to hormonal effects.
- Gastrointestinal disturbances: Such as nausea and vomiting.
Contraindications[edit]
Spironolactone is contraindicated in patients with:
- Severe renal impairment
- Hyperkalemia
- Addison's disease
